ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma.

Daniel P Regan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.